| Filed On | Filing |
|---|---|
| 13 Nov 2026 | SCHEDULE 13G/A |
| 13 Nov 2026 | Form 4 |
| 13 Nov 2026 | SCHEDULE 13G/A |
| 12 Nov 2026 | Form 4 |
| 12 Nov 2026 | 144 |
| 09 Nov 2026 | 144 |
| 29 Oct 2026 | 424B3 |
| 29 Oct 2026 | 424B3 |
| 29 Oct 2026 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying consolidated financial statements of Omnetics Connector Corporation (the "Company"), which comprise the consolidated balance sheet as of December 31, 2025, and the related consolidated statements of opera... |
| 29 Oct 2026 | 10-Q |
| 28 Oct 2026 |
8-K: Financial Statements and Exhibits
BLOOMFIELD, Conn., October 28, 2026 – Arxis, Inc. (NASDAQ: ARXS) (the “Company” or “Arxis”), a leading designer and manufacturer of proprietary, mission-critical electronic and mechanical engineered components, today reported financial r... |
| 22 Oct 2026 | EFFECT |
| 22 Oct 2026 | 424B3 |
| 13 Oct 2026 | S-1 |
| 21 Sep 2026 | SCHEDULE 13G |
| 21 Aug 2026 |
Form 4: Roth Jason Aaron, See Remarks
Received 34,098 shares as a grant or award |
| 18 Aug 2026 |
8-K: Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities
BLOOMFIELD, Conn., August 18, 2026 — Arxis, Inc. (NASDAQ: ARXS) (the “Company” or “Arxis”), a publicly-traded industrial compounder formed in partnership with Arcline Investment Management (“Arcline”), today announced that it has complet... |
| 14 Aug 2026 | SCHEDULE 13G |
| 12 Aug 2026 | SCHEDULE 13G |
| 12 Aug 2026 | SCHEDULE 13G |
Loading...